Advertisement

The Scientist

» clinical trials and evolution

Most Recent

image: Science and Politics in 2012

Science and Politics in 2012

By | December 19, 2012

This year, US politics was dominated by the run-up to October elections, with science policy issues playing a role here and elsewhere around the world.

1 Comment

image: Failing Alzheimer’s Test?

Failing Alzheimer’s Test?

By | December 19, 2012

Two new studies claim that a shoddy test may have caused Alzheimer’s drugs to fail in clinical trials.

0 Comments

image: Top Science Scandals of 2012

Top Science Scandals of 2012

By | December 17, 2012

This year’s roundup of bad behavior in the life sciences and new initiatives to prevent misconduct

20 Comments

image: Conserved Chromatin?

Conserved Chromatin?

By | December 10, 2012

Archaea packages DNA around histones in a similar way to eukaryotes, suggesting that fitting a large genome into a small space was not the original role of chromatin.

2 Comments

image: Speaking of Science

Speaking of Science

By | December 1, 2012

December 2012's selection of notable quotes

0 Comments

image: The Plastic Genome

The Plastic Genome

By | December 1, 2012

The poxvirus stockpiles genes when it needs to adapt.

1 Comment

image: Chelation Therapy Under Scrutiny

Chelation Therapy Under Scrutiny

By | November 15, 2012

A clinical trial suggesting the heart benefits of the controversial treatment draws criticism from the scientific community.

6 Comments

image: BioTime Seeks Geron Stem Cell Assets

BioTime Seeks Geron Stem Cell Assets

By | November 13, 2012

Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.

1 Comment

image: Charles Darwin for Congress

Charles Darwin for Congress

By | November 13, 2012

Nominated as a write-in candidate as a protest against the anti-science incumbent, famed naturalist Charles Darwin won 4,000 congressional votes in a Georgia county.

1 Comment

image: Setback for Malaria Vaccine

Setback for Malaria Vaccine

By | November 9, 2012

The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Diagenode Inc
Diagenode Inc
Advertisement
The Scientist
The Scientist